Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
EHA
Filter by Topic
2018 EHA Congress Highlights
EHA 2014
EHA 2016
EHA 2016 – Leukemia
Higher-Dose Daunorubicin Is Effective in Patients with AML Who Harbor FLT3-ITD Mutations
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
Ibrutinib plus Bendamustine and Rituximab (BR) in Previously Treated CLL/SLL: 2-Year Follow-Up Data from the HELIOS Study
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
Innovative Therapies in CLL: Saturday, June 11
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
Length of Time on Treatment Observed in Ibrutinib Clinical Trials Is Reproducible After Assessment of Real-World Data
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
Outcomes Associated with Conventional Salvage Therapy in Patients with Refractory or Relapsed AML and IDH1/IDH2 Mutations
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
Overall Survival Benefit in Relapsed and Refractory B-Cell ALL Patients Receiving Inotuzumab Ozogamicin
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
Presidential Symposium: Friday, June 10
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Stem-Cell Transplantation for De Novo ALL in Adults
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
Response-Adapted Sequential Azacitidine and Intensive Chemotherapy Is Effective in Patients Aged >60 Years with Newly Diagnosed AML
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
Valuable New Prognostic Scoring System in Patients with CML Receiving Nilotinib as Initial Treatment
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
Page 2 of 3
1
2
3
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma